@article{5dcecff2c528493e9f08d0ea0e57a40f,
title = "Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy",
abstract = "This guideline is intended to provide a basis for informed decision-making regarding genetic testing to identify those individuals who will not benefit from codeine therapy, as well as those who are at an increased risk for codeine-induced toxicity. This guideline addresses the following key questions: 1) Should genetic testing for CYP2D6 be performed in patients prior to the initiation of codeine therapy? 2) How should patients with an indication for codeine therapy be managed based on their genotyping results for CYP2D6?",
keywords = "CYP2D6, Codeine, Guidelines, Morphine, Pharmacogenetics",
author = "{CPNDS Clinical Recommendations Group} and Parvaz Madadi and Ursula Amstutz and Michael Rieder and Shinya Ito and Vincent Fung and Soomi Hwang and Jacques Turgeon and Veronique Michaud and Gideon Koren and Carleton, {Bruce C.} and Hayden, {Michael R.} and Ross, {Colin J.} and Stuart MacLeod and Rod Rassekh and Gillian Lauder and Anne Smith and Liam Brunham and Shear, {Neil H.} and Geoffrey Liu and Richard Kim and Maurica Maher and David Flockhart",
year = "2013",
month = nov,
day = "6",
language = "אנגלית",
volume = "20",
pages = "e369--e396--e369--e396",
journal = "Journal of Population Therapeutics and Clinical Pharmacology",
issn = "1710-6222",
publisher = "Dougmar Publishing Group Inc.",
number = "3",
}